< Back to Article

Dose optimization of an adjuvanted peptide-based personalized neoantigen melanoma vaccine

Table 2

Neoantigen Vaccine dose.

Peptide dose and adjuvant:peptide ratio converted from clinical trial data for patients with melanoma [33].

doi: https://doi.org/10.1371/journal.pcbi.1011247.t002